Aridis Pharmaceuticals Inc
NASDAQ:ARDS
Aridis Pharmaceuticals Inc
NASDAQ:ARDS
Price:
0.059 USD
4.42%
Market Closed
Updated:
May 10, 2024
Balance Sheet
Balance Sheet Decomposition
Aridis Pharmaceuticals Inc
Aridis Pharmaceuticals Inc
| Current Assets | 4.1m |
| Cash & Short-Term Investments | 35k |
| Receivables | 517k |
| Other Current Assets | 3.6m |
| Non-Current Assets | 2.4m |
| PP&E | 1.6m |
| Intangibles | 13k |
| Other Non-Current Assets | 827k |
| Current Liabilities | 17.5m |
| Accounts Payable | 8.8m |
| Accrued Liabilities | 8.3m |
| Other Current Liabilities | 395k |
| Non-Current Liabilities | 854k |
| Other Non-Current Liabilities | 854k |
Balance Sheet
Aridis Pharmaceuticals Inc
Aridis Pharmaceuticals Inc
Currency: USD
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
3
|
22
|
25
|
24
|
21
|
8
|
18
|
5
|
|
| Cash Equivalents |
3
|
22
|
25
|
24
|
21
|
8
|
18
|
5
|
|
| Total Receivables |
1
|
0
|
0
|
2
|
0
|
0
|
0
|
1
|
|
| Accounts Receivables |
1
|
0
|
0
|
2
|
0
|
0
|
0
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
2
|
5
|
4
|
6
|
6
|
|
| Total Current Assets |
4
|
22
|
25
|
28
|
26
|
13
|
24
|
12
|
|
| PP&E Net |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
|
| PP&E Gross |
0
|
0
|
1
|
1
|
1
|
1
|
1
|
2
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Total Assets |
4
N/A
|
23
+481%
|
26
+17%
|
32
+19%
|
28
-12%
|
15
-46%
|
27
+77%
|
15
-45%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
1
|
1
|
2
|
2
|
2
|
5
|
6
|
|
| Accrued Liabilities |
2
|
2
|
2
|
3
|
3
|
1
|
6
|
10
|
|
| Short-Term Debt |
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
15
|
19
|
21
|
20
|
|
| Total Current Liabilities |
6
|
2
|
3
|
5
|
19
|
22
|
33
|
37
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
|
| Other Liabilities |
0
|
6
|
12
|
0
|
5
|
1
|
1
|
2
|
|
| Total Liabilities |
6
N/A
|
9
+48%
|
15
+72%
|
5
-65%
|
24
+359%
|
24
-2%
|
40
+68%
|
39
-2%
|
|
| Equity | |||||||||
| Common Stock |
26
|
59
|
74
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
11
|
20
|
48
|
71
|
101
|
123
|
165
|
196
|
|
| Additional Paid In Capital |
17
|
25
|
15
|
97
|
104
|
114
|
152
|
166
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
|
| Total Equity |
2
N/A
|
14
N/A
|
11
-17%
|
26
+130%
|
4
-86%
|
9
N/A
|
13
-51%
|
24
-85%
|
|
| Total Liabilities & Equity |
4
N/A
|
23
+481%
|
26
+17%
|
32
+19%
|
28
-12%
|
15
-46%
|
27
+77%
|
15
-45%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
8
|
8
|
8
|
8
|
9
|
10
|
18
|
27
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
